Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Cipla Limited

Cipla Limited Recalls

All product recalls associated with Cipla Limited.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Oct 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–3 of 3 recalls

Phytonadione Injectable Emulsion (Cipla) – stability failure (2025)

Failed Stability Specifications: Observed OOS results: eg results for colour index

Class IIModerate

FDAOct 31, 2025Nationwide• Cipla Limited

Nevirapine Extended Release Tablets (Cipla) – failed dissolution (2018)

Failed Dissolution Specifications.

Class IIModerate

FDADec 14, 2018Nationwide• Cipla Limited

Levalbuterol Inhalation Solution (Cipla) – Impurity Specification Failure (2015)

Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.

Class IIILow

FDAApr 24, 2015Nationwide• Cipla Limited